Liver study on blood cancer drug onureg halted early
NCT ID NCT05209295
First seen Jan 12, 2026 · Last updated May 07, 2026 · Updated 18 times
Summary
This study aimed to understand how moderate or severe liver impairment changes the way the body handles the drug Onureg (oral azacitidine) in adults with certain blood cancers. Researchers planned to compare drug levels and safety in people with and without liver problems. However, the study was terminated early after enrolling only 2 participants, so no meaningful conclusions were reached.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEOPLASMS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Local Institution
Cleveland, Ohio, 44106, United States
-
Local Institution - 0010
ABB, Buenos Aires F.D., C1199ABB, Argentina
-
Local Institution - 0011
Pilar, Buenos Aires, 1629, Argentina
-
Local Institution - 0012
Buenos Aires, 1426, Argentina
-
Local Institution - 0014
Buenos Aires, Buenos Aires F.D., C1118AAT, Argentina
-
Local Institution - 0015
Pamplona, Navarre, 31008, Spain
-
Local Institution - 0017
Barcelona, Barcelona [Barcelona], 08035, Spain
-
Local Institution - 0018
Badalona, Barcelona [Barcelona], 08916, Spain
-
Local Institution - 0069
Detroit, Michigan, 48202, United States
-
Local Institution - 0074
Hamburg, 20246, Germany
-
Local Institution - 0075
Halle, Saxony-Anhalt, 06120, Germany
-
Local Institution - 0076
Augsburg, Bavaria, 86156, Germany
-
Local Institution - 0078
Salamanca, 37007, Spain
-
Local Institution - 0083
Iowa City, Iowa, 52242, United States
-
Local Institution - 0084
Bogota, Cundinamarca, 111151, Colombia
-
Local Institution - 0085
Bogotá, Bogota D.C., 110131, Colombia
-
Local Institution - 0086
Piedecuesta, Santander Department, 681017, Colombia
-
Local Institution - 9003
Charlottesville, Virginia, 22903, United States
Conditions
Explore the condition pages connected to this study.